Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ANAVEX LIFE SCIENCES CORP.ex99-1.htm




 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT
 
 
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported) October 21, 2011
 
 
ANAVEX LIFE SCIENCES CORP.
(Exact name of registrant as specified in its charter)
 
Nevada
000-51652
20-8365999
(State or other jurisdiction of
(Commission
(IRS Employer
incorporation)
File Number)
Identification No.)

50 Harrison Street, Suite 315A, Hoboken, New Jersey
07030
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code 1-866-505-2895
 
 
N/A
(Former name or former address, if changed since last report.)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 
 

 
Item 5.02             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
Effective October 21, 2011, Alison Ayers has resigned as a director of our company.
 
Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
99.1


 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ANAVEX LIFE SCIENCES CORP.


/s/ Harvey Lalach                                                                           
Harvey Lalach
President, Chief Operating Officer, Interim CFO and Director
Date:  October 21, 2011

 
3